Tag: Association of the British Pharmaceutical Industry
‘One year on, no medicine has entered NHSE’s Innovative Medicines Fund’
The NHS England(NHSE) Innovative Medicines Fund (IMF) should be efficiently utilised to expedite patient access to potentially valuable new medications, thereby incentivising the pharmaceutical...
Report: NHS faces over £1 billion loss as 85 biologics go off-patent in five years
The NHS is on track to miss out on savings of over a billion pounds as patents for a new lineup of 85 biologics...
ABPI urges govt to scrap hike in repayment rate for drugmakers
The Association of the British Pharmaceutical Industry (ABPI) on Thursday (February 2) called for the government to scrap its plans to raise the repayment...
AbbVie, Eli Lilly exit UK drug pricing deal
Pharmaceutical companies AbbVie and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry body said on Monday.
Companies are increasingly arguing that...
ABPI promotes new approach for individual data on payments
The Association of the British Pharmaceutical Industry (ABPI) today released a new guidance to pharmaceutical companies using Disclosure UK which it said will boost...
ABPI calls for “meaningful investment” in UK life sciences
In its submission to the Treasury ahead of the Comprehensive Spending Review this autumn, the Association of the British Pharmaceutical Industry (ABPI) says it...